Muzammal Mateen Azhar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muzammal Mateen Azhar has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Tahir Maqbool
Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan
7 shared publications - Awais Altaf
Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan
3 shared publications - Javed Anver Qureshi
Centre for Research in Molecular Medicine, Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore 54660, Pakistan
3 shared publications - Sadia Naz
Department of Allied Health Sciences, The University of Lahore, Lahore 54660, Pakistan
3 shared publications - Shehwar Nadeem
Centre for Research in Molecular Medicine, Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore 54660, Pakistan
3 shared publications - Awais Altaf
University of Lahore, Pakistan
2 shared publications
Latest Publications
- 12 November 2026
- Published by Bentham Science Publishers Ltd. in Current Stem Cell Research & Therapy
- Vol. 21
Bone Marrow Stem Cells Augmented with Tendon Tissue Lysate Promote Enhanced Achilles Tendon Healing
Introduction/Objective: Tendon injuries, particularly of the Achilles tendon, are common in both athletic and aging populations. Conventional repair strategies often result in suboptimal healing due to the inherent avascularity and limited regenerative potential of tendon tissue. For tendon regeneration, stem cells have become a promising treatment option. Preconditioning Bone Marrow- Derived Stem Cells (BMSCs) with Tendon Tissue Lysate (TTL), a heterogeneous tissue-derived preparation, may influence tenogenic differentiation. The objective of the study was to evaluate the effect of tendon tissue lysate preconditioning on Bone Marrow-Derived Stem Cells (BMSCs) viability and tenogenic biomarker expression in a rat model of Achilles tendon injury. Methods: Both in vitro and in vivo evaluations were performed. Bone Marrow-Derived Stem Cells (BMSCs) were isolated from rats, cultured, and treated with Tendon Tissue Lysate (TTL). Cell viability was assessed using MTT, crystal violet, and trypan blue assays. Tenogenic differentiation was evaluated via ELISA for Tenomodulin and TGF-β1. For in vivo assessment, forty Sprague-Dawley rats were randomly divided into four groups (n=10/group): (1) healthy control, (2) tendon injury only, (3) injury treated with BMSCs, and (4) tendon injury treated with BMSCs preconditioned with TTL. Achilles tendon injury was induced in groups 2–4, followed by treatments via direct injection into the injury site in groups 3 and 4, except group 2. Serum biomarkers (CRP, IL-6, TGF-β1, TNMD) were quantified, and further tendon healing was evaluated histologically. Results: TTL did not significantly affect viability. Morphology and ELISA indicated a favorable tenogenic response at 100 μg/mL. In vivo, rats treated with TTL-preconditioned BMSCs demonstrated more organized tendon histology, increased TNMD and TGF-β1 levels, and reduced CRP and IL-6 compared to other groups. Discussion: The results suggest that Tendon Tissue Lysate (TTL) may support tenogenic differentiation of BMSCs. TTL may provide an optimum microenvironment that supports tendon repair. Increased levels of TNMD and TGF-β1 are consistent with tendon maturation and extracellular remodeling. Histological analysis shows improvement in collagen alignment. Conclusion: Overall, preconditioning of BMSCs with tendon tissue lysate was associated with favorable tenogenic, inflammatory, and histological changes related to tendon repair. TTL represents a promising biological adjunct for optimizing stem cell-based therapies in tendon tissue engineering.
- 12 November 2026
- Published by Bentham Science Publishers Ltd. in Current Stem Cell Research & Therapy
- Vol. 21
Bone Marrow Stem Cells Augmented with Tendon Tissue Lysate Promote Enhanced Achilles Tendon Healing
Introduction/Objective: Tendon injuries, particularly of the Achilles tendon, are common in both athletic and aging populations. Conventional repair strategies often result in suboptimal healing due to the inherent avascularity and limited regenerative potential of tendon tissue. For tendon regeneration, stem cells have become a promising treatment option. Preconditioning Bone Marrow- Derived Stem Cells (BMSCs) with Tendon Tissue Lysate (TTL), a heterogeneous tissue-derived preparation, may influence tenogenic differentiation. The objective of the study was to evaluate the effect of tendon tissue lysate preconditioning on Bone Marrow-Derived Stem Cells (BMSCs) viability and tenogenic biomarker expression in a rat model of Achilles tendon injury. Methods: Both in vitro and in vivo evaluations were performed. Bone Marrow-Derived Stem Cells (BMSCs) were isolated from rats, cultured, and treated with Tendon Tissue Lysate (TTL). Cell viability was assessed using MTT, crystal violet, and trypan blue assays. Tenogenic differentiation was evaluated via ELISA for Tenomodulin and TGF-β1. For in vivo assessment, forty Sprague-Dawley rats were randomly divided into four groups (n=10/group): (1) healthy control, (2) tendon injury only, (3) injury treated with BMSCs, and (4) tendon injury treated with BMSCs preconditioned with TTL. Achilles tendon injury was induced in groups 2–4, followed by treatments via direct injection into the injury site in groups 3 and 4, except group 2. Serum biomarkers (CRP, IL-6, TGF-β1, TNMD) were quantified, and further tendon healing was evaluated histologically. Results: TTL did not significantly affect viability. Morphology and ELISA indicated a favorable tenogenic response at 100 μg/mL. In vivo, rats treated with TTL-preconditioned BMSCs demonstrated more organized tendon histology, increased TNMD and TGF-β1 levels, and reduced CRP and IL-6 compared to other groups. Discussion: The results suggest that Tendon Tissue Lysate (TTL) may support tenogenic differentiation of BMSCs. TTL may provide an optimum microenvironment that supports tendon repair. Increased levels of TNMD and TGF-β1 are consistent with tendon maturation and extracellular remodeling. Histological analysis shows improvement in collagen alignment. Conclusion: Overall, preconditioning of BMSCs with tendon tissue lysate was associated with favorable tenogenic, inflammatory, and histological changes related to tendon repair. TTL represents a promising biological adjunct for optimizing stem cell-based therapies in tendon tissue engineering.
- Open Access
- 16 January 2026
- Published by Society of Eminent Biological Scientists in International Journal of Applied and Experimental Biology
- Vol. 6 (1)
Ameliorative properties of citronellol against alcohol-induced toxicity in human embryonic kidney (HEK) cells
Alcohol-induced toxicity is a significant health concern that can lead to organ damage, including renal impairment. Citronellol has demonstrated several bioactive properties, including antioxidant, anti-inflammatory, antimicrobial, and anticancer activities. The study aimed to investigate the ameliorative properties of citronellol against alcohol-induced toxicity in human embryonic kidney (HEK) cells. The HEK cells were exposed to ethanol to induce cellular toxicity, followed by treatment with different concentrations of citronellol to assess its cytoprotective potential. Cell viability was examined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and crystal violet (CV) assay. Oxidative stress parameters, including glutathione levels and superoxide dismutase (SOD) activity, were measured. Apoptotic potential was evaluated by assessing the expression levels of CYR61 and p53 proteins. Experiments were conducted in triplicate. Citronellol treatment improved cell viability in the ethanol-exposed HEK cells without causing cytotoxicity. A significant reduction in CYR61 protein expression was observed, while the p53 protein levels showed only a mild elevation. In addition, citronellol treatment did not significantly alter glutathione reductase or SOD activities compared with the control group. Overall, these findings suggest that citronellol confers protective effects against ethanol-induced cytotoxicity in human embryonic kidney cells, potentially by enhancing cell viability, attenuating oxidative stress, and modulating apoptosis-related pathways.
- 16 January 2026
- Published by Society of Eminent Biological Scientists in International Journal of Applied and Experimental Biology
- Vol. 6 (1)
Open AccessAmeliorative properties of citronellol against alcohol-induced toxicity in human embryonic kidney (HEK) cells
Alcohol-induced toxicity is a significant health concern that can lead to organ damage, including renal impairment. Citronellol has demonstrated several bioactive properties, including antioxidant, anti-inflammatory, antimicrobial, and anticancer activities. The study aimed to investigate the ameliorative properties of citronellol against alcohol-induced toxicity in human embryonic kidney (HEK) cells. The HEK cells were exposed to ethanol to induce cellular toxicity, followed by treatment with different concentrations of citronellol to assess its cytoprotective potential. Cell viability was examined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and crystal violet (CV) assay. Oxidative stress parameters, including glutathione levels and superoxide dismutase (SOD) activity, were measured. Apoptotic potential was evaluated by assessing the expression levels of CYR61 and p53 proteins. Experiments were conducted in triplicate. Citronellol treatment improved cell viability in the ethanol-exposed HEK cells without causing cytotoxicity. A significant reduction in CYR61 protein expression was observed, while the p53 protein levels showed only a mild elevation. In addition, citronellol treatment did not significantly alter glutathione reductase or SOD activities compared with the control group. Overall, these findings suggest that citronellol confers protective effects against ethanol-induced cytotoxicity in human embryonic kidney cells, potentially by enhancing cell viability, attenuating oxidative stress, and modulating apoptosis-related pathways.
- 1 November 2025
- Published by Bentham Science Publishers Ltd. in Current Stem Cell Research & Therapy
- Vol. 20 (10) , 1094-1111
Regenerative Potential of Umbilical Cord Blood-derived Stromal Cells along with Phytosterol Campesterol in Wound Healing of a Rat Model
Introduction: Mesenchymal stem cells derived from umbilical cord blood (UCB-MSCs) have a well-known role in fastening the wound healing process due to their less immune rejection, anti-inflammatory effects, and their role in cellular growth. Campesterol is a nutritional phytosterol with extensive health values and a competitor of cholesterol in the blood. Campesterol shares some anti-inflammatory effects via its regulation of inflammatory markers by inhibiting the proinflammatory cytokines (including TNF-α, TNF-α, and IL-6) levels. Method: The purpose of this study was to assess the ameliorative role of combined therapy (campesterol and UCB-MSCs) in wound healing without immune rejection. The study comprised both invitro and in-vivo experiments. In-vitro analysis included assessments of the cell viability of campesterol on UCBMSCs using MTT, crystal blue, trypan blue, and cell scratch assays. For in-vivo trials, superficial burn wounds were created on Sprague Dawley rats to evaluate the effects of campesterol, UCB-MSCs, and their combination on healing outcomes. Tissue regeneration progress in the wound vicinity was assessed using H&E staining and ELISA (inflammatory and growth markers) analysis. Result: Results of in-vitro experiments indicated that campesterol at concentrations of 10μg, 20μg, and 30μg demonstrated the most efficient cell viability. Moreover, a 30ug dose of campesterol along with UCBMSCs was further applied, leading to smooth and uncomplicated healing in the animal models. H&E staining showed nearly normal skin tissue while hematological and biochemical markers were near to control. Serum levels of tissue growth promoter factors, including VEGF and collagen- 3, were higher, and pro-inflammatory markers (such as TGF-β1, TNF-α, and IL-6) were lower at the same time. Conclusion: The results of the combined (MSCs and campesterol) therapy showed enhanced wound healing abilities. However, further studies are recommended to explore new aspects of this promising therapeutic approach of UCBSCs along with steroid derivative campesterol.
- 1 November 2025
- Published by Bentham Science Publishers Ltd. in Current Stem Cell Research & Therapy
- Vol. 20 (10) , 1094-1111
Regenerative Potential of Umbilical Cord Blood-derived Stromal Cells along with Phytosterol Campesterol in Wound Healing of a Rat Model
Introduction: Mesenchymal stem cells derived from umbilical cord blood (UCB-MSCs) have a well-known role in fastening the wound healing process due to their less immune rejection, anti-inflammatory effects, and their role in cellular growth. Campesterol is a nutritional phytosterol with extensive health values and a competitor of cholesterol in the blood. Campesterol shares some anti-inflammatory effects via its regulation of inflammatory markers by inhibiting the proinflammatory cytokines (including TNF-α, TNF-α, and IL-6) levels. Method: The purpose of this study was to assess the ameliorative role of combined therapy (campesterol and UCB-MSCs) in wound healing without immune rejection. The study comprised both invitro and in-vivo experiments. In-vitro analysis included assessments of the cell viability of campesterol on UCBMSCs using MTT, crystal blue, trypan blue, and cell scratch assays. For in-vivo trials, superficial burn wounds were created on Sprague Dawley rats to evaluate the effects of campesterol, UCB-MSCs, and their combination on healing outcomes. Tissue regeneration progress in the wound vicinity was assessed using H&E staining and ELISA (inflammatory and growth markers) analysis. Result: Results of in-vitro experiments indicated that campesterol at concentrations of 10μg, 20μg, and 30μg demonstrated the most efficient cell viability. Moreover, a 30ug dose of campesterol along with UCBMSCs was further applied, leading to smooth and uncomplicated healing in the animal models. H&E staining showed nearly normal skin tissue while hematological and biochemical markers were near to control. Serum levels of tissue growth promoter factors, including VEGF and collagen- 3, were higher, and pro-inflammatory markers (such as TGF-β1, TNF-α, and IL-6) were lower at the same time. Conclusion: The results of the combined (MSCs and campesterol) therapy showed enhanced wound healing abilities. However, further studies are recommended to explore new aspects of this promising therapeutic approach of UCBSCs along with steroid derivative campesterol.
- Open Access
- 15 October 2025
- Published by Society of Eminent Biological Scientists in International Journal of Applied and Experimental Biology
Cytoprotective role of p-cymene against alcohol-induced toxicity in human embryonic kidney cells
P-Cymene (p-isopropyl toluene) is a monocyclic monoterpene and is the main compound of many aromatic plant species. p-cymene also exhibits various pharmacological properties, including antimicrobial, antioxidant, anti-inflammatory, antidiabetic, antiviral, and antitumor activities. p-cymene also acts as a strong anti-inflammatory and antioxidant agent. Alcohol use is widespread in the Western world and is found to be nephrotoxic, and can cause kidney injury, especially during pregnancy and kidney development during intrauterine life. Alcohol can lead to reduced levels of antioxidants and increased synthesis of pro-inflammatory markers. This study aimed to investigate the cytoprotective role of p-cymene against alcohol-induced toxicity in human embryonic kidney (HEK293) cells. In this study, we developed four groups: a negative control group, a positive control group, an injury group, and an injury plus treatment group. Injury was induced by ethanol, and then different concentrations of p-cymene, i.e., 50 µM, 100 µM, and 500 µM, were added to check the cytoprotective action of p-cymene. The MTT assay and oxidative stress marker (glutathione reductase) were assessed to check cell viability. The KIM-1 and 8-OHdG ELISA were done to evaluate the apoptotic pathways. The results concluded that the 500 µM treatment increased cell viability more than the other levels. According to the MTT Assay, Crystal Violet Assay, and Trypan Blue Assay, p-cymene increased cell viability in ethanol-injured cells. KIM-1 ELISA showed lower levels of kidney injury molecule-1 in p-cymene-treated cells. While 8-OHdG ELISA showed that 8-hydroxy guanosine levels were also reduced in the cells treated with p-cymene, in contrast to cells left untreated. In the Antioxidant assay, a GSH ELISA was performed, and the glutathione value increased in treated cells. In this research, it has been observed that p-cymene has a cytoprotective role against alcohol-induced toxicity in human embryonic kidney cells.
- 15 October 2025
- Published by Society of Eminent Biological Scientists in International Journal of Applied and Experimental Biology
Open AccessCytoprotective role of p-cymene against alcohol-induced toxicity in human embryonic kidney cells
P-Cymene (p-isopropyl toluene) is a monocyclic monoterpene and is the main compound of many aromatic plant species. p-cymene also exhibits various pharmacological properties, including antimicrobial, antioxidant, anti-inflammatory, antidiabetic, antiviral, and antitumor activities. p-cymene also acts as a strong anti-inflammatory and antioxidant agent. Alcohol use is widespread in the Western world and is found to be nephrotoxic, and can cause kidney injury, especially during pregnancy and kidney development during intrauterine life. Alcohol can lead to reduced levels of antioxidants and increased synthesis of pro-inflammatory markers. This study aimed to investigate the cytoprotective role of p-cymene against alcohol-induced toxicity in human embryonic kidney (HEK293) cells. In this study, we developed four groups: a negative control group, a positive control group, an injury group, and an injury plus treatment group. Injury was induced by ethanol, and then different concentrations of p-cymene, i.e., 50 µM, 100 µM, and 500 µM, were added to check the cytoprotective action of p-cymene. The MTT assay and oxidative stress marker (glutathione reductase) were assessed to check cell viability. The KIM-1 and 8-OHdG ELISA were done to evaluate the apoptotic pathways. The results concluded that the 500 µM treatment increased cell viability more than the other levels. According to the MTT Assay, Crystal Violet Assay, and Trypan Blue Assay, p-cymene increased cell viability in ethanol-injured cells. KIM-1 ELISA showed lower levels of kidney injury molecule-1 in p-cymene-treated cells. While 8-OHdG ELISA showed that 8-hydroxy guanosine levels were also reduced in the cells treated with p-cymene, in contrast to cells left untreated. In the Antioxidant assay, a GSH ELISA was performed, and the glutathione value increased in treated cells. In this research, it has been observed that p-cymene has a cytoprotective role against alcohol-induced toxicity in human embryonic kidney cells.
- 30 June 2025
- Published by Journal of Liaquat University of Medical and Health Sciences (JLUMHS) in JOURNAL OF LIAQUAT UNIVERSITY OF MEDICAL & HEALTH SCIENCES
- Vol. 24 (02) , 175-180
Expression and Characterization of Trastuzumab in Baby Hamster Kidney Cell Line to Check its Anti-Cancer Activity in HCC 1954
- 30 June 2025
- Published by Journal of Liaquat University of Medical and Health Sciences (JLUMHS) in JOURNAL OF LIAQUAT UNIVERSITY OF MEDICAL & HEALTH SCIENCES
- Vol. 24 (02) , 175-180
Expression and Characterization of Trastuzumab in Baby Hamster Kidney Cell Line to Check its Anti-Cancer Activity in HCC 1954
- Open Access
- 18 March 2025
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 25 (8) , 1751-1764
Adefovir anticancer potential: Network pharmacology, anti-proliferative and apoptotic effects in HeLa cells
Cervical cancer presents a significant healthcare challenge due to recurrent disease and drug resistance, highlighting the urgent need for novel therapeutic strategies. Network pharmacology facilitates drug repurposing by elucidating multi-target mechanisms of action. Adefovir, an acyclic nucleotide analog, has shown promising potential in cervical cancer treatment, particularly in HeLa cells. In vitro studies have demonstrated that adefovir inhibits HeLa cell proliferation by enhancing apoptosis while maintaining a low cytotoxicity profile at therapeutic concentrations, making it an attractive candidate for further exploration. A combined network pharmacology and in vitro study was conducted to investigate the molecular mechanism of adefovir against cervical cancer. Potential gene targets for adefovir and cervical cancer were predicted using database analysis. Hub targets were identified, and protein-protein interaction (PPI) networks were constructed. Molecular docking assessed adefovir's binding affinity to key targets. In vitro cytotoxic assays, including 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and crystal violet assays, were performed using 96-well plates to evaluate anti-proliferative effects in HeLa cells. Apoptosis was assessed via p53 immunocytochemistry Enzyme-Linked Immunosorbent Assay (ELISA), while Vascular Endothelial Growth Factor ELISA (VEGF ELISA) was used to measure cell proliferation. Venn analysis identified 144 common targets between adefovir and cervical cancer. Network analysis revealed key hub targets involved in oncogenic pathways. Molecular docking demonstrated strong binding between adefovir and Mitogen-Activated Protein Kinase 3 (MAPK3) and SRC proteins. In vitro, adefovir significantly suppressed HeLa cell viability, with an Inhibitory Concentration 50 (IC50) of 7.8 µM, outperforming 5-Fluorouracil (5-FU). Additionally, it induced apoptosis via p53 activation and inhibited cell proliferation through VEGF suppression. These integrated computational and experimental findings suggest that adefovir exerts multi-targeted effects against cervical cancer. Its promising preclinical efficacy warrants further investigation as a potential alternative therapy.
- 18 March 2025
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 25 (8) , 1751-1764
Open AccessAdefovir anticancer potential: Network pharmacology, anti-proliferative and apoptotic effects in HeLa cells
Cervical cancer presents a significant healthcare challenge due to recurrent disease and drug resistance, highlighting the urgent need for novel therapeutic strategies. Network pharmacology facilitates drug repurposing by elucidating multi-target mechanisms of action. Adefovir, an acyclic nucleotide analog, has shown promising potential in cervical cancer treatment, particularly in HeLa cells. In vitro studies have demonstrated that adefovir inhibits HeLa cell proliferation by enhancing apoptosis while maintaining a low cytotoxicity profile at therapeutic concentrations, making it an attractive candidate for further exploration. A combined network pharmacology and in vitro study was conducted to investigate the molecular mechanism of adefovir against cervical cancer. Potential gene targets for adefovir and cervical cancer were predicted using database analysis. Hub targets were identified, and protein-protein interaction (PPI) networks were constructed. Molecular docking assessed adefovir's binding affinity to key targets. In vitro cytotoxic assays, including 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and crystal violet assays, were performed using 96-well plates to evaluate anti-proliferative effects in HeLa cells. Apoptosis was assessed via p53 immunocytochemistry Enzyme-Linked Immunosorbent Assay (ELISA), while Vascular Endothelial Growth Factor ELISA (VEGF ELISA) was used to measure cell proliferation. Venn analysis identified 144 common targets between adefovir and cervical cancer. Network analysis revealed key hub targets involved in oncogenic pathways. Molecular docking demonstrated strong binding between adefovir and Mitogen-Activated Protein Kinase 3 (MAPK3) and SRC proteins. In vitro, adefovir significantly suppressed HeLa cell viability, with an Inhibitory Concentration 50 (IC50) of 7.8 µM, outperforming 5-Fluorouracil (5-FU). Additionally, it induced apoptosis via p53 activation and inhibited cell proliferation through VEGF suppression. These integrated computational and experimental findings suggest that adefovir exerts multi-targeted effects against cervical cancer. Its promising preclinical efficacy warrants further investigation as a potential alternative therapy.
- Open Access
Apolipoprotein E Gene Variation in Pakistani Subjects with Type 2 Diabetes with and without Cardiovascular Complications
Background: Apolipoprotein E (APOE) gene polymorphism has been implicated in the pathogenesis of various metabolic disorders, including type 2 diabetes mellitus (T2DM). Type 2 diabetes mellitus (T2DM) is a major public health concern worldwide, including in Pakistan. Cardiovascular problems linked with T2DM have a significant impact on individuals and society. The goal of this study is to investigate the relationship between Apolipoprotein E (ApoE) genotypes, dyslipidemia, and cardiovascular complications such as ischemic heart disease (IHD) and stroke. Methods: This study was carried out on 260 subjects divided into controls and diabetics. The diabetics were further divided into four subgroups such as D1: diabetics without cardiovascular issues, D2: diabetics with heart disease, D3: diabetics with stroke, and D4: diabetics with both heart disease and stroke. Anthropometric parameters (age, BMI) and risk factors (smoking, diabetes duration, hypertension) were assessed in all groups. Serum levels of TC, TG, LDL, HDL, VLDL, creatinine, BSF, and HbA1c were also measured. Apolipoprotein E gene polymorphism was determined using PCR-RFLP. Results: Hypertension, BMI, and dyslipidemia are defined as elevated levels of total cholesterol, triglycerides, LDL, and VLDL, and decreased levels of HDL. Uncontrolled hyperglycemia (elevated fasting blood sugar and glycated hemoglobin) in T2DM was linked to vascular complications such as IHD and stroke. Hypertension was prevalent in 79.3% of the population. Stage 2 hypertension was more prevalent in all age groups. It was also noted that common genotypes in the Pakistani population are 3/3, 4/4, 2/3, and 3/4. The frequency of genotypes 3/4 and 2/3 is highest in diabetics with stroke. Genotype 3/3 is present frequently in diabetics with IHD/stroke and patients with both these complications. However, genotype 4/4 is most frequently found in diabetics with IHD. Conclusions: It is concluded that BMI, hypertension, hyperglycemia, atherosclerosis, and dyslipidemia are linked with cardiovascular complications of type 2 diabetes. Apolipoprotein E gene polymorphism is associated with cardiovascular disease in patients with diabetes by affecting the lipid profile.
Open AccessApolipoprotein E Gene Variation in Pakistani Subjects with Type 2 Diabetes with and without Cardiovascular Complications
Background: Apolipoprotein E (APOE) gene polymorphism has been implicated in the pathogenesis of various metabolic disorders, including type 2 diabetes mellitus (T2DM). Type 2 diabetes mellitus (T2DM) is a major public health concern worldwide, including in Pakistan. Cardiovascular problems linked with T2DM have a significant impact on individuals and society. The goal of this study is to investigate the relationship between Apolipoprotein E (ApoE) genotypes, dyslipidemia, and cardiovascular complications such as ischemic heart disease (IHD) and stroke. Methods: This study was carried out on 260 subjects divided into controls and diabetics. The diabetics were further divided into four subgroups such as D1: diabetics without cardiovascular issues, D2: diabetics with heart disease, D3: diabetics with stroke, and D4: diabetics with both heart disease and stroke. Anthropometric parameters (age, BMI) and risk factors (smoking, diabetes duration, hypertension) were assessed in all groups. Serum levels of TC, TG, LDL, HDL, VLDL, creatinine, BSF, and HbA1c were also measured. Apolipoprotein E gene polymorphism was determined using PCR-RFLP. Results: Hypertension, BMI, and dyslipidemia are defined as elevated levels of total cholesterol, triglycerides, LDL, and VLDL, and decreased levels of HDL. Uncontrolled hyperglycemia (elevated fasting blood sugar and glycated hemoglobin) in T2DM was linked to vascular complications such as IHD and stroke. Hypertension was prevalent in 79.3% of the population. Stage 2 hypertension was more prevalent in all age groups. It was also noted that common genotypes in the Pakistani population are 3/3, 4/4, 2/3, and 3/4. The frequency of genotypes 3/4 and 2/3 is highest in diabetics with stroke. Genotype 3/3 is present frequently in diabetics with IHD/stroke and patients with both these complications. However, genotype 4/4 is most frequently found in diabetics with IHD. Conclusions: It is concluded that BMI, hypertension, hyperglycemia, atherosclerosis, and dyslipidemia are linked with cardiovascular complications of type 2 diabetes. Apolipoprotein E gene polymorphism is associated with cardiovascular disease in patients with diabetes by affecting the lipid profile.
- Open Access
- 1 April 2024
- Published by MDPI AG in Preprints.org
Apolipoprotein E Gene Variation in Pakistani Type 2 Diabetic Subjects with and without Cardiovascular Complications
Background Apolipoprotein E (APOE) gene polymorphism has been implicated in the pathogenesis of various metabolic disorders, including type 2 diabetes mellitus (T2DM). Type 2 diabetes mellitus (T2DM) is a major public health concern worldwide, including in Pakistan. Cardiovascular problems linked with T2DM have a significant impact on people and society. The study's goal is to investigate the relationship between Apolipoprotein E (ApoE) genotypes, lipid profiles, and cardiovascular complications such as ischemic heart disease (IHD) and stroke. Methods: This study was carried out on 260 subjects, divided into control D1: Diabetics without cardiovascular issues. D2: Diabetics with heart disease. D3: Diabetics with stroke. D4: Diabetics with both heart disease and stroke. Anthropometric parameters (age, BMI) and risk factors (smoking, diabetes duration, hypertension) were assessed in all groups. Serum levels of TC, TG, LDL, HDL, VLDL, creatinine, BSF, and HbA1c were measured. Apolipoprotein E gene polymorphism was determined using PCR-RFLP. Results: Hypertension, BMI, and dyslipidemia, defined as elevated levels of total cholesterol, triglycerides, LDL, HDL, and VLDL, as well as uncontrolled hyperglycemia (elevated fasting blood sugar and glycated hemoglobin) in T2DM, were linked to vascular complications such as IHD and stroke. Hypertension was prevalent in 75.4% of the population, with greater rates among the elderly. Stage 2 hypertension was more prevalent in all age groups. Apolipoprotein E gene polymorphism was discovered, with genotypes 3/3, 4/4, 2/3, and 3/4 being the most prevalent. Genotype 3/4 was more common in diabetics who had IHD/stroke or both problems, whereas genotype 2/3 was linked to DM and stroke. Conclusion: It is concluded that BMI, hypertension, hyperglycemia, atherosclerosis, and dyslipidemia are linked with cardiovascular complications of type 2 diabetes. Apolipoprotein E gene polymorphism is associated with cardiovascular disease in diabetic patients by affecting the lipid profile.
- 1 April 2024
- Published by MDPI AG in Preprints.org
Open AccessApolipoprotein E Gene Variation in Pakistani Type 2 Diabetic Subjects with and without Cardiovascular Complications
Background Apolipoprotein E (APOE) gene polymorphism has been implicated in the pathogenesis of various metabolic disorders, including type 2 diabetes mellitus (T2DM). Type 2 diabetes mellitus (T2DM) is a major public health concern worldwide, including in Pakistan. Cardiovascular problems linked with T2DM have a significant impact on people and society. The study's goal is to investigate the relationship between Apolipoprotein E (ApoE) genotypes, lipid profiles, and cardiovascular complications such as ischemic heart disease (IHD) and stroke. Methods: This study was carried out on 260 subjects, divided into control D1: Diabetics without cardiovascular issues. D2: Diabetics with heart disease. D3: Diabetics with stroke. D4: Diabetics with both heart disease and stroke. Anthropometric parameters (age, BMI) and risk factors (smoking, diabetes duration, hypertension) were assessed in all groups. Serum levels of TC, TG, LDL, HDL, VLDL, creatinine, BSF, and HbA1c were measured. Apolipoprotein E gene polymorphism was determined using PCR-RFLP. Results: Hypertension, BMI, and dyslipidemia, defined as elevated levels of total cholesterol, triglycerides, LDL, HDL, and VLDL, as well as uncontrolled hyperglycemia (elevated fasting blood sugar and glycated hemoglobin) in T2DM, were linked to vascular complications such as IHD and stroke. Hypertension was prevalent in 75.4% of the population, with greater rates among the elderly. Stage 2 hypertension was more prevalent in all age groups. Apolipoprotein E gene polymorphism was discovered, with genotypes 3/3, 4/4, 2/3, and 3/4 being the most prevalent. Genotype 3/4 was more common in diabetics who had IHD/stroke or both problems, whereas genotype 2/3 was linked to DM and stroke. Conclusion: It is concluded that BMI, hypertension, hyperglycemia, atherosclerosis, and dyslipidemia are linked with cardiovascular complications of type 2 diabetes. Apolipoprotein E gene polymorphism is associated with cardiovascular disease in diabetic patients by affecting the lipid profile.
- Open Access
- 1 January 2024
- Published by Green Publication
- Vol. 31 (3) , 325-337
THERAPEUTIC INSIGHTS OF VITAMIN D IN THE MANAGEMENT OF TYPE 2 DIABETIC NEUROPATHY
Background: Diabetes mellitus is derived from the Greek term diabetes, meaning siphon - to pass through, and the Latin word mellitus, meaning sweet. The most common consequence is neuropathy, namely distal symmetric polyneuropathy (referred to as diabetic neuropathy in this primer). Diabetic neuropathy is a loss of sensory function that begins distally in the lower limbs and is accompanied by discomfort and significant morbidity. Over time, at least 50% of diabetics develop diabetic neuropathy. The study aimed to identify the impact of oxidative markers (glutathione (GSH), advanced oxidation protein products (AOPP), advanced glycation end products (AGEs), malondialdehyde (MDA), and inflammatory biomarkers (interleukin-6, IL-6, TNF-α, and myeloperoxidase (MPO)) on the development of diabetic neuropathy along with routinely used biochemical parameters. Materials and Method: This was a case-control study. All the selected patients were screened and enrolled by convenient non-probability sampling technique at the social security hospital Lahore. Written Informed consent was obtained before enrollment of the study subjects. A total of 150 patients enrolled in the study, and they were divided into three groups, 50 subjects with type 2 diabetic neuropathy taking oral antidiabetics only and 50 diagnosed diabetic neuropathy (DN) subjects taking adjunct oral vitamin D therapy, 50 healthy individuals as a control group. Five mL of venous blood sample was taken from the antecubital vein of each participant. Statistical analysis was performed by GraphPad. The results of all variables were evaluated by using one-way ANOVA. Results: The mean value of biochemical parameters (WBCs, platelets, HbA1c, BSF, triglycerides, LDL, HDL, serum creatinine, and liver function tests, were increased in diabetics with neuropathy compared to the control and treated group. There was a significant improvement in these parameters after vitamin D therapy, the mean values of MDA, AGE, and AOPPs in type 2 diabetics with neuropathy were significantly increased compared to the control group and a significant decrease was noticed after vitamin D supplementation in the vitamin D group. GSH level was decreased in type 2 diabetics with DPN patients as compared to the control group. A significant increase in GSH was noticed in the vitamin D group. In addition, IL-6, TNFα, and MPO levels were also increased in the case of diabetic neuropathy as compared to controls. However, a significant decrease in the levels was seen in the vitamin D group. Conclusions: ROS-mediated injuries in type 2 diabetics with neuropathy can be prevented by the restoration of an antioxidant defense system, through the administration of antioxidant agents and micronutrients like vitamin D as an adjunct therapy along with antidiabetics drugs insulin/oral antidiabetics. Moreover, increased levels of inflammatory mediators are responsible for enhancing inflammation in patients with diabetic neuropathy. Vitamin D helps to decrease the levels of inflammatory biomarkers in subjects with diabetic neuropathy.
- 1 January 2024
- Published by Green Publication
- Vol. 31 (3) , 325-337
Open AccessTHERAPEUTIC INSIGHTS OF VITAMIN D IN THE MANAGEMENT OF TYPE 2 DIABETIC NEUROPATHY
Background: Diabetes mellitus is derived from the Greek term diabetes, meaning siphon - to pass through, and the Latin word mellitus, meaning sweet. The most common consequence is neuropathy, namely distal symmetric polyneuropathy (referred to as diabetic neuropathy in this primer). Diabetic neuropathy is a loss of sensory function that begins distally in the lower limbs and is accompanied by discomfort and significant morbidity. Over time, at least 50% of diabetics develop diabetic neuropathy. The study aimed to identify the impact of oxidative markers (glutathione (GSH), advanced oxidation protein products (AOPP), advanced glycation end products (AGEs), malondialdehyde (MDA), and inflammatory biomarkers (interleukin-6, IL-6, TNF-α, and myeloperoxidase (MPO)) on the development of diabetic neuropathy along with routinely used biochemical parameters. Materials and Method: This was a case-control study. All the selected patients were screened and enrolled by convenient non-probability sampling technique at the social security hospital Lahore. Written Informed consent was obtained before enrollment of the study subjects. A total of 150 patients enrolled in the study, and they were divided into three groups, 50 subjects with type 2 diabetic neuropathy taking oral antidiabetics only and 50 diagnosed diabetic neuropathy (DN) subjects taking adjunct oral vitamin D therapy, 50 healthy individuals as a control group. Five mL of venous blood sample was taken from the antecubital vein of each participant. Statistical analysis was performed by GraphPad. The results of all variables were evaluated by using one-way ANOVA. Results: The mean value of biochemical parameters (WBCs, platelets, HbA1c, BSF, triglycerides, LDL, HDL, serum creatinine, and liver function tests, were increased in diabetics with neuropathy compared to the control and treated group. There was a significant improvement in these parameters after vitamin D therapy, the mean values of MDA, AGE, and AOPPs in type 2 diabetics with neuropathy were significantly increased compared to the control group and a significant decrease was noticed after vitamin D supplementation in the vitamin D group. GSH level was decreased in type 2 diabetics with DPN patients as compared to the control group. A significant increase in GSH was noticed in the vitamin D group. In addition, IL-6, TNFα, and MPO levels were also increased in the case of diabetic neuropathy as compared to controls. However, a significant decrease in the levels was seen in the vitamin D group. Conclusions: ROS-mediated injuries in type 2 diabetics with neuropathy can be prevented by the restoration of an antioxidant defense system, through the administration of antioxidant agents and micronutrients like vitamin D as an adjunct therapy along with antidiabetics drugs insulin/oral antidiabetics. Moreover, increased levels of inflammatory mediators are responsible for enhancing inflammation in patients with diabetic neuropathy. Vitamin D helps to decrease the levels of inflammatory biomarkers in subjects with diabetic neuropathy.
- 1 September 2021
- Published by College of Agriculture and Food Science, University of the Philippines Los Banos in The Philippine Agricultural Scientist
- Vol. 104 (3) , 259-276
Optimization of Ethanol Production from Enzymatically Saccharified Biomass of Acid-Pretreated Rice Straw
The substrate of rice (Oryza sativa) straw employed in this study was procured from local market and stored in polyethene bags until needed. The study was conducted to find out the effects of process optimization of ethanol production from enzymatically saccharified biomass of acid-pretreated rice straw. The results indicated that acid pretreatment has reduced lignin content about 50%. Resultantly, pretreatment raised cellulose contents up to 52% making it suitable for enzymatic saccharification. Optimization of saccharification illustrated that parameters such as biomass, enzyme concentration, temperature, incubation time and agitation indeed affected the action of cellulase on pretreated biomass releasing sugars up to 31.0g/L. The results clearly indicate the need for optimization at every point in the ethanol production process for efficient use of resources and maximum yield without wastage. Among various operational modes of fermentation studied, such as batch, semi-continuous and continuous, the semi-continuous process gave better ethanol yield of 23.4 g/L. This implies potential use of the process in industrial grade ethanol production. Collectively the study has shown that rice straw can serve as a lignocellulosic substrate, utilizing acid pretreatment for cellulose exposure and enzymatic saccharification to release fermentable sugars for production of ethanol.
- 1 September 2021
- Published by College of Agriculture and Food Science, University of the Philippines Los Banos in The Philippine Agricultural Scientist
- Vol. 104 (3) , 259-276
Optimization of Ethanol Production from Enzymatically Saccharified Biomass of Acid-Pretreated Rice Straw
The substrate of rice (Oryza sativa) straw employed in this study was procured from local market and stored in polyethene bags until needed. The study was conducted to find out the effects of process optimization of ethanol production from enzymatically saccharified biomass of acid-pretreated rice straw. The results indicated that acid pretreatment has reduced lignin content about 50%. Resultantly, pretreatment raised cellulose contents up to 52% making it suitable for enzymatic saccharification. Optimization of saccharification illustrated that parameters such as biomass, enzyme concentration, temperature, incubation time and agitation indeed affected the action of cellulase on pretreated biomass releasing sugars up to 31.0g/L. The results clearly indicate the need for optimization at every point in the ethanol production process for efficient use of resources and maximum yield without wastage. Among various operational modes of fermentation studied, such as batch, semi-continuous and continuous, the semi-continuous process gave better ethanol yield of 23.4 g/L. This implies potential use of the process in industrial grade ethanol production. Collectively the study has shown that rice straw can serve as a lignocellulosic substrate, utilizing acid pretreatment for cellulose exposure and enzymatic saccharification to release fermentable sugars for production of ethanol.